The European Patent Office (EPO) upholds bit.bio’s patent for its dual genomic safe harbour technology, opti-ox™, securing the broadest possible claims for programming of pluripotent stem cells (PSCs) into any cell type. Much like how CRISPR transformed genome editing, opti-ox establishes a new paradigm for the safe, consistent, and scalable manufacture of iPSC-derived cells. The successful […]

Collaboration to Enable Sequencing of Cells while Preserving Their Viability Zürich, Switzerland, and Vienna, Austria – Cytosurge AG, a leader in single-cell manipulation, and Lexogen, a pioneer in RNA sequencing solutions, have announced their partnership to advance live-cell sequencing (Live-seq). The collaboration integrates Cytosurge’s FluidFM® OMNIUM platform with Lexogen’s LUTHOR HD kit to offer a streamlined […]

Automation-Ready Reagents Used with the Hamilton Robotics Liquid-Handler Streamlines and Helps Accelerate Lab Work Leading to Genomic Sequencing FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial launch of the first in a family of high-throughput, robotics-compatible reagent kits that will enable automation to […]

ROCKVILLE, Md. — MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovative bioprocessing applications, today announced the appointment of Cynthia Collins to the Company’s Board of Directors as a non-executive director, effective October 14, 2024. Collins […]

Amsterdam-based LUMICKS signs €20 million venture debt with EIB to accelerate the development and launch of its new product, designed to advance immunotherapy development for cancer research. LUMICKS’ next generation high-throughput cell avidity platform aims to transform the drug discovery process by replacing traditional screening methods, expediting development for life-saving treatments, and improving reliability in […]

MaxCyte Appoints Ali Soleymannezhad as Chief Commercial Officer Rockville, MD – MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovative bioprocessing applications, today announced the appointment of Ali Soleymannezhad as Chief Commercial Officer, effective as of September 11, 2024. In […]

Combined single-cell spatial genomics and multiplex proteomic profiling technologies position merged company to accelerate discoveries in foundational and clinical research CAMBRIDGE, Mass. – Vizgen, Inc., a life science company dedicated to improving human health by visualizing single-cell spatial genomics information, and Ultivue, Inc., a market leader in multiplex proteomic biomarker detection and advanced AI-driven spatial tissue […]

Bruker Spatial Biology Offers the Widest Range of Industry-leading Multiomic Spatial Biology Platforms to Scientists Globally  BILLERICA, Massachusetts – Bruker Corporation (Nasdaq: BRKR) today announced the formation of a new division, Bruker Spatial Biology, offering the most diverse and comprehensive solutions for spatial biology. Bruker Spatial Biology brings together in operational coordination three entities: the […]

PALO ALTO, Calif. – Curio Bioscience today announced the worldwide availability of Curio Trekker, a new single-cell spatial mapping kit that converts single-cell genomics measurements into tissue-specific spatial data. More than 80 early access customers have already validated this powerful new tool to advance discovery research in cancer biology, neuroscience, developmental sciences and beyond. Making […]

The NanoSpark® platform is designed to geometrically orient its antibodies for optimal immune cell activation, tapping into powerful receptor clustering biology to produce higher yields, healthier cells, and differentiated performance. BERKELEY, Calif. — Nanotein Technologies, Inc. (“Nanotein”), a technology development company with next-generation immune cell activation reagents leveraging its proprietary NanoSpark® platform, and Akron Bio (“Akron”), a leading […]